Aug 31, 2026 08:00AM
Aug 24, 2026 08:01AM
Aug 24, 2026 08:00AM
Aug 19, 2026 08:00AM
Aug 17, 2026 06:49AM
Aug 12, 2026 04:15PM
Aug 3, 2026 04:16PM AEON Biopharma regains NYSE American listing compliance
Aug 3, 2026 04:15PM
Jul 14, 2026 08:00AM
Jul 14, 2026 08:00AM
Jun 4, 2026 07:03AM
Jun 4, 2026 07:00AM
May 14, 2026 04:05PM
Apr 24, 2026 04:05PM AEON Biopharma Sets Annual Shareholder Meeting
Apr 6, 2026 05:54AM
Apr 3, 2026 04:10PM
Apr 3, 2026 04:05PM
Mar 30, 2026 04:06PM
Mar 30, 2026 04:05PM
Mar 25, 2026 08:00AM
Mar 25, 2026 08:00AM AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
Mar 9, 2026 04:05PM
Mar 9, 2026 04:05PM
Mar 5, 2026 04:05PM
Jan 21, 2026 04:05PM
Jan 21, 2026 04:05PM
Dec 19, 2025 06:00PM
Dec 15, 2025 04:05PM AEON Biopharma signs debt exchange deal with Daewoong
Dec 15, 2025 04:05PM
Nov 20, 2025 08:30AM
Nov 14, 2025 08:30AM
Nov 14, 2025 08:30AM
May 23, 2025 04:05PM
May 19, 2025 04:05PM
May 14, 2025 04:05PM AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
Apr 25, 2025 04:05PM
Apr 25, 2025 04:05PM
Apr 21, 2025 04:10PM
Apr 21, 2025 04:05PM
Apr 21, 2025 04:05PM
Mar 27, 2025 04:05PM
Mar 27, 2025 04:05PM AEON Biopharma Announces CEO Transition
Mar 24, 2025 04:05PM
Mar 4, 2025 08:00AM
Feb 24, 2025 02:01PM
Feb 24, 2025 02:00PM
Feb 7, 2025 04:05PM
Feb 7, 2025 04:05PM
Jan 7, 2025 09:37AM AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering
Jan 6, 2025 09:03AM

329,906 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All